Literature DB >> 8773140

Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients.

L Claudio1.   

Abstract

Alzheimer's disease (AD) is a major cause of dementia. Characteristic neuropathological features of AD include neurofibrillary tangles, senile plaques, amyloid angiopathy and microvascular atrophy. The ultra-structure of the microvascular atrophy in AD and its pathogenetic significance have not been defined. This report presents an analysis of ultrastructural and morphometric features in the cerebral microvasculature of five brain biopsy specimens from AD patients. The cerebral microvasculature normally constitutes the blood-brain barrier (BBB), characterized by interendothelial tight junctions, few pinocytotic vesicles and high mitochondrial content in endothelial cells. In the AD brain biopsy tissue analyzed in the present article, data for endothelial cells were expressed as percentage of cytoplasmic area occupied by the respective organelles. The values for vesicular content ranged from 0.49% to 1.17% and were inversely correlated with mitochondrial content, which ranged from 7.04% to 2.88%. These results indicate decreased mitochondrial content and increased pinocytotic vesicles as compared to values obtained previously in endothelium from multiple sclerosis patients and in laboratory animals. Other findings such as accumulation of collagen in vascular basement membranes and focal necrotic changes in endothelial cells are further indications of BBB disruption. These data, together with earlier reports, suggest that dysfunction of the BBB is a characteristic feature of AD.

Entities:  

Mesh:

Year:  1996        PMID: 8773140     DOI: 10.1007/s004010050386

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  56 in total

1.  Formation and structural organization of the barrier on the outer surface of the brain.

Authors:  V A Otellin; D E Korzhevskii
Journal:  Neurosci Behav Physiol       Date:  2004-05

Review 2.  Membrane biophysics and mechanics in Alzheimer's disease.

Authors:  Xiaoguang Yang; Sholpan Askarova; James C-M Lee
Journal:  Mol Neurobiol       Date:  2010-05-01       Impact factor: 5.590

Review 3.  Vascular complications of cystathionine β-synthase deficiency: future directions for homocysteine-to-hydrogen sulfide research.

Authors:  Richard S Beard; Shawn E Bearden
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-22       Impact factor: 4.733

Review 4.  Targeting the brain: rationalizing the novel methods of drug delivery to the central nervous system.

Authors:  Shailendra Joshi; Eugene Ornstein; Jeffrey N Bruce
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

5.  Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future.

Authors:  Gene L Bowman; Joseph F Quinn
Journal:  Aging health       Date:  2008-02-01

6.  Chronic Hypertension Leads to Neurodegeneration in the TgSwDI Mouse Model of Alzheimer's Disease.

Authors:  Anna Kruyer; Nadine Soplop; Sidney Strickland; Erin H Norris
Journal:  Hypertension       Date:  2015-05-04       Impact factor: 10.190

Review 7.  The vascular basement membrane in the healthy and pathological brain.

Authors:  Maj S Thomsen; Lisa J Routhe; Torben Moos
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-28       Impact factor: 6.200

8.  Brain Atrophy, Anti-Smooth Muscle Antibody and Cognitive Impairment: An Association Study.

Authors:  Paroni Giulia; Lauriola Michele; Fontana Andrea; D'Onofrio Grazia; Ciccone Filomena; Paris Francesco; Cascavilla Leandro; Urbano Maria; Gravina Carolina; Copetti Massimiliano; Greco Antonio
Journal:  Aging Dis       Date:  2015-11-24       Impact factor: 6.745

Review 9.  Agile delivery of protein therapeutics to CNS.

Authors:  Xiang Yi; Devika S Manickam; Anna Brynskikh; Alexander V Kabanov
Journal:  J Control Release       Date:  2014-06-21       Impact factor: 9.776

Review 10.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.